NEWS
Clinical Trials Point to New Options for Advanced Prostate Cancer
Two more treatments for men with advanced prostate cancer could soon be available, according to updated findings from two phase III clinical trials presented in San Francisco last week at the 2012 Genitourinary Cancers Symposium. Read more > >
Additional Surgery after Breast-Conserving Surgery Varies Widely
Study highlights lack of consensus on what defines successful tumor removalComparing Prostate Cancer Treatments Shows Newer Isn't Always Better
Older, less expensive, less toxic treatments may be better, but more studies are neededOral HPV Infections May Explain Why Some Head and Neck Cancers are More Common in Men
Cancer-linked HPV-16 infections are more common in men than in womenCancer Screening Rates Lag Behind National Target Levels
Breast, cervical, and colorectal cancer screening fall below Healthy People 2020 goalsHPV Testing with Self-Collected Samples May Be Valid Cervical Cancer Screening Method
Method could expand access to screening in rural and low-resource areasGenetic Studies Uncover Clues to Childhood Brain Cancers
Some cases may involve changes in the chromatin structureAlso in the Journals: CDC Advisory Committee Strengthens Recommendation for HPV Vaccination in Males
COMMENTARY
Global Health through Collaboration and Leadership
by Dr. Nils Daulaire
To mark World Cancer Day on February 4, the director of the Office of Global Affairs at the U.S. Department of Health and Human Services talks about why the United States should be involved in initiatives to improve global health.
A Conversation with Drs. Christopher Kinsinger and Henry Rodriguez about Sharing Proteomics Data
Experts from NCI's Office of Cancer Clinical Proteomics Research discuss recommendations for setting standards to ensure data quality.
IN DEPTH
Studies Highlight Complexities of Treating Advanced Head and Neck Cancer
Results lead to different recommendations for clinical trials in the United States and Europe
Connecting the Dots: Network Analysis Helps Public Health Researchers Get the Big Picture
Mapping key relationships, whether in cells or society, may reveal factors that influence human health
Featured Clinical Trial: Cetuximab and Radiotherapy for HPV-Associated Oropharynx Cancer
Will substitution of cisplatin with cetuximab result in comparable 5-year overall survival?
UPDATES
FDA Update
- Drug to Treat Basal Cell Skin Cancer Approved after Priority Review
- Drug Approved for Advanced Kidney Cancer
- Imatinib Granted Expanded Use in Patients with Rare Gastrointestinal Tumors
Notes
- NCI Wins Two Awards for Tech Transfer Excellence
- Kevin White to Speak on Genomic Networks in Development and Cancer
- NCI to Hold Symposium on Translational Genomics
- New Issue of CCR Connections Published
- Smartphone App to Help Teens Quit Smoking Now Available
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
